Insider filing · IDXX
Sophie V. Vandebroek
Director
profile →
IDEXX Laboratories, Inc.
IDXX · Healthcare · 39 filings in 24 months
ticker →
Sophie V. Vandebroek sold $628K of IDEXX Laboratories (IDXX)
Executed May 9 2025, disclosed May 13 2025, 4 days later.
Value, as filed
$628K
1,279 sh × $491.34
Executed
May 9 2025
the trade date, as filed
Disclosed
May 13 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SVSophie V. Vandebroek (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in IDEXX Laboratories, Inc. (IDXX). The largest single filing was $920K of IDXX (1,464 sh across 2 lots, as filed), executed Feb 17.
The name
IDXXHealthcare · IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Sophie V. Vandebroek in IDXX
IDXXSALE
IDEXX Laboratories, Inc.
$920K1,464 sh across 2 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET IDXXSALE IDEXX Laboratories, Inc. $145K
344 sh × $420.44
Exec Nov 27 2024
Filed Nov 29 2024 · 5:30 PM ET